INDEGENE
|
The Current P/B Ratio of INDEGENE is 5.11.
Share Price | ₹548.9 | Jul 29,2025 |
Market Cap | ₹13,177.9 Cr | |
Book Value | ₹2,579.5 Cr | Mar2025 - Consolidated Results |
Price/Book | 5.11x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹13,177.9 Cr] as on Jul 29,2025
(/) Book Value [ ₹2,579.5 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 5.11x ]
Thus, for INDEGENE , the investors are currently willing to pay '5.11 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.07x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2025 at 5.37x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
INDEGENE | 2,579.50 | 5.11 | 13,177.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 72,218.00 | 5.68 | 410,466.0 |
DIVIS LABORATORIES LTD | 14,969.00 | 11.84 | 177,298.0 |
CIPLA LTD | 31,079.30 | 4.09 | 127,140.0 |
TORRENT PHARMACEUTICALS LTD | 7,590.69 | 16.80 | 127,538.0 |
DR REDDYS LABORATORIES LTD | 33,404.90 | 3.25 | 108,500.0 |
MANKIND PHARMA LTD | 14,288.70 | 7.37 | 105,363.0 |
ZYDUS LIFESCIENCES LTD | 23,953.10 | 4.18 | 100,095.0 |
LUPIN LTD | 17,119.50 | 5.29 | 90,634.7 |
AUROBINDO PHARMA LTD | 32,653.30 | 2.06 | 67,262.6 |
ABBOTT INDIA LTD | 4,204.27 | 17.56 | 73,812.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.06x |
Max industry PB | 17.56x |
Median industry PB | 5.29x |
Average industry PB | 7.57x |
You may also like the below Video Courses